Clinical Trial Update: Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) [Phase 1]

View source ↗

Summary

Phase 1 trial of MK-7162 in combination with pembrolizumab in adults with advanced solid tumors has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Neoplasms

Drugs mentioned

• MK-7162
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2021-11-15